Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of California, Los Angeles National Multiple Sclerosis Society |
---|---|
Information provided by: | University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT00607126 |
Locomotor training is a new exercise modality that emphasizes task specificity to promote learning and neural plasticity. It ihas been reported to improve walking in patients with stroke, spinal cord injury and cerebral palsy. In this study, 40 patients with impaired ambulation due to Multiple Sclerosis will be randomized to receive 36 sessions of either locomotor training or an standard resistive exercise intervention.The locomotor training will be accomplished via a robotic device, the Lokomat, which will move the patient's legs on a treadmill while they are suspended in a harness.
Condition | Intervention | Phase |
---|---|---|
Multiple Sclerosis |
Device: Lokomat Procedure: resistive training |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Robotic Locomotor Training in Persons With Multiple Sclerosis |
Estimated Enrollment: | 40 |
Study Start Date: | July 2006 |
Estimated Study Completion Date: | August 2009 |
Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
locomotor training using body weight support on a treadmill, using robotic device to provide locomotor training
|
Device: Lokomat
locomotor training using body weight support on a treadmill
|
2: Active Comparator
resistive training
|
Procedure: resistive training
resistive training using theraband and/or weights
|
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
UCLA | |
Los Angeles, California, United States, 90095 |
Principal Investigator: | Barbara S Giesser, MD | University of California, Los Angeles |
Responsible Party: | UCLA School of Medicine ( Barbara Giesser, MD ) |
Study ID Numbers: | 06-04-064-02, RG3724-A-4 |
Study First Received: | January 22, 2008 |
Last Updated: | February 13, 2009 |
ClinicalTrials.gov Identifier: | NCT00607126 History of Changes |
Health Authority: | United States: Institutional Review Board |
impaired ambulation |
Autoimmune Diseases Multiple Sclerosis Demyelinating Diseases |
Demyelinating Autoimmune Diseases, CNS Sclerosis Autoimmune Diseases of the Nervous System |
Pathologic Processes Autoimmune Diseases Multiple Sclerosis Immune System Diseases Demyelinating Diseases |
Nervous System Diseases Demyelinating Autoimmune Diseases, CNS Sclerosis Autoimmune Diseases of the Nervous System |